Global Neurological Disorder Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Neurological Disorder Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Neurological Disorder Drugs market are covered in Chapter 9:
Merck & Co.
Bayer AG
Novartis AG
Teva Pharmaceutical Industries Ltd.
AstraZeneca
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
In Chapter 5 and Chapter 7.3, based on types, the Neurological Disorder Drugs market from 2017 to 2027 is primarily split into:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
In Chapter 6 and Chapter 7.4, based on applications, the Neurological Disorder Drugs market from 2017 to 2027 covers:
Hospital
Clinic
Home
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Neurological Disorder Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Neurological Disorder Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Neurological Disorder Drugs market are covered in Chapter 9:
Merck & Co.
Bayer AG
Novartis AG
Teva Pharmaceutical Industries Ltd.
AstraZeneca
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
In Chapter 5 and Chapter 7.3, based on types, the Neurological Disorder Drugs market from 2017 to 2027 is primarily split into:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
In Chapter 6 and Chapter 7.4, based on applications, the Neurological Disorder Drugs market from 2017 to 2027 covers:
Hospital
Clinic
Home
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Neurological Disorder Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Neurological Disorder Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 NEUROLOGICAL DISORDER DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Neurological Disorder Drugs Market
1.2 Neurological Disorder Drugs Market Segment by Type
1.2.1 Global Neurological Disorder Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Neurological Disorder Drugs Market Segment by Application
1.3.1 Neurological Disorder Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Neurological Disorder Drugs Market, Region Wise (2017-2027)
1.4.1 Global Neurological Disorder Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.4 China Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.6 India Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Neurological Disorder Drugs (2017-2027)
1.5.1 Global Neurological Disorder Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Neurological Disorder Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Neurological Disorder Drugs Market
2 INDUSTRY OUTLOOK
2.1 Neurological Disorder Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Neurological Disorder Drugs Market Drivers Analysis
2.4 Neurological Disorder Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Neurological Disorder Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Neurological Disorder Drugs Industry Development
3 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Neurological Disorder Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Neurological Disorder Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Neurological Disorder Drugs Average Price by Player (2017-2022)
3.4 Global Neurological Disorder Drugs Gross Margin by Player (2017-2022)
3.5 Neurological Disorder Drugs Market Competitive Situation and Trends
3.5.1 Neurological Disorder Drugs Market Concentration Rate
3.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NEUROLOGICAL DISORDER DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Neurological Disorder Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Neurological Disorder Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Neurological Disorder Drugs Market Under COVID-19
4.5 Europe Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Neurological Disorder Drugs Market Under COVID-19
4.6 China Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Neurological Disorder Drugs Market Under COVID-19
4.7 Japan Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Neurological Disorder Drugs Market Under COVID-19
4.8 India Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Neurological Disorder Drugs Market Under COVID-19
4.9 Southeast Asia Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Neurological Disorder Drugs Market Under COVID-19
4.10 Latin America Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Neurological Disorder Drugs Market Under COVID-19
4.11 Middle East and Africa Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Neurological Disorder Drugs Market Under COVID-19
5 GLOBAL NEUROLOGICAL DISORDER DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Neurological Disorder Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Neurological Disorder Drugs Price by Type (2017-2022)
5.4 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Antipsychotic (2017-2022)
5.4.2 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Hypnotic & Sedative (2017-2022)
5.4.3 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Analgesics (2017-2022)
5.4.4 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Anticoagulants (2017-2022)
5.4.5 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Neurological Disorder Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2017-2022)
6.3.3 Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2017-2022)
7 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST (2022-2027)
7.1 Global Neurological Disorder Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Neurological Disorder Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Neurological Disorder Drugs Price and Trend Forecast (2022-2027)
7.2 Global Neurological Disorder Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Neurological Disorder Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Neurological Disorder Drugs Revenue and Growth Rate of Antipsychotic (2022-2027)
7.3.2 Global Neurological Disorder Drugs Revenue and Growth Rate of Hypnotic & Sedative (2022-2027)
7.3.3 Global Neurological Disorder Drugs Revenue and Growth Rate of Analgesics (2022-2027)
7.3.4 Global Neurological Disorder Drugs Revenue and Growth Rate of Anticoagulants (2022-2027)
7.3.5 Global Neurological Disorder Drugs Revenue and Growth Rate of Others (2022-2027)
7.4 Global Neurological Disorder Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.2 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Clinic(2022-2027)
7.4.3 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Home(2022-2027)
7.5 Neurological Disorder Drugs Market Forecast Under COVID-19
8 NEUROLOGICAL DISORDER DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Neurological Disorder Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Neurological Disorder Drugs Analysis
8.6 Major Downstream Buyers of Neurological Disorder Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Neurological Disorder Drugs Industry
9 PLAYERS PROFILES
9.1 Merck & Co.
9.1.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.1.3 Merck & Co. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.2.3 Bayer AG Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Novartis AG
9.3.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.3.3 Novartis AG Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Teva Pharmaceutical Industries Ltd.
9.4.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.4.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AstraZeneca
9.5.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.5.3 AstraZeneca Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.6.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 GlaxoSmithKline plc
9.7.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.7.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Boehringer Ingelheim GmbH
9.8.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.8.3 Boehringer Ingelheim GmbH Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Neurological Disorder Drugs Market
1.2 Neurological Disorder Drugs Market Segment by Type
1.2.1 Global Neurological Disorder Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Neurological Disorder Drugs Market Segment by Application
1.3.1 Neurological Disorder Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Neurological Disorder Drugs Market, Region Wise (2017-2027)
1.4.1 Global Neurological Disorder Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.4 China Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.6 India Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Neurological Disorder Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Neurological Disorder Drugs (2017-2027)
1.5.1 Global Neurological Disorder Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Neurological Disorder Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Neurological Disorder Drugs Market
2 INDUSTRY OUTLOOK
2.1 Neurological Disorder Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Neurological Disorder Drugs Market Drivers Analysis
2.4 Neurological Disorder Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Neurological Disorder Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Neurological Disorder Drugs Industry Development
3 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Neurological Disorder Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Neurological Disorder Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Neurological Disorder Drugs Average Price by Player (2017-2022)
3.4 Global Neurological Disorder Drugs Gross Margin by Player (2017-2022)
3.5 Neurological Disorder Drugs Market Competitive Situation and Trends
3.5.1 Neurological Disorder Drugs Market Concentration Rate
3.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NEUROLOGICAL DISORDER DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Neurological Disorder Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Neurological Disorder Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Neurological Disorder Drugs Market Under COVID-19
4.5 Europe Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Neurological Disorder Drugs Market Under COVID-19
4.6 China Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Neurological Disorder Drugs Market Under COVID-19
4.7 Japan Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Neurological Disorder Drugs Market Under COVID-19
4.8 India Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Neurological Disorder Drugs Market Under COVID-19
4.9 Southeast Asia Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Neurological Disorder Drugs Market Under COVID-19
4.10 Latin America Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Neurological Disorder Drugs Market Under COVID-19
4.11 Middle East and Africa Neurological Disorder Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Neurological Disorder Drugs Market Under COVID-19
5 GLOBAL NEUROLOGICAL DISORDER DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Neurological Disorder Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Neurological Disorder Drugs Price by Type (2017-2022)
5.4 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Antipsychotic (2017-2022)
5.4.2 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Hypnotic & Sedative (2017-2022)
5.4.3 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Analgesics (2017-2022)
5.4.4 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Anticoagulants (2017-2022)
5.4.5 Global Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Neurological Disorder Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2017-2022)
6.3.3 Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2017-2022)
7 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST (2022-2027)
7.1 Global Neurological Disorder Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Neurological Disorder Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Neurological Disorder Drugs Price and Trend Forecast (2022-2027)
7.2 Global Neurological Disorder Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Neurological Disorder Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Neurological Disorder Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Neurological Disorder Drugs Revenue and Growth Rate of Antipsychotic (2022-2027)
7.3.2 Global Neurological Disorder Drugs Revenue and Growth Rate of Hypnotic & Sedative (2022-2027)
7.3.3 Global Neurological Disorder Drugs Revenue and Growth Rate of Analgesics (2022-2027)
7.3.4 Global Neurological Disorder Drugs Revenue and Growth Rate of Anticoagulants (2022-2027)
7.3.5 Global Neurological Disorder Drugs Revenue and Growth Rate of Others (2022-2027)
7.4 Global Neurological Disorder Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.2 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Clinic(2022-2027)
7.4.3 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Home(2022-2027)
7.5 Neurological Disorder Drugs Market Forecast Under COVID-19
8 NEUROLOGICAL DISORDER DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Neurological Disorder Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Neurological Disorder Drugs Analysis
8.6 Major Downstream Buyers of Neurological Disorder Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Neurological Disorder Drugs Industry
9 PLAYERS PROFILES
9.1 Merck & Co.
9.1.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.1.3 Merck & Co. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.2.3 Bayer AG Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Novartis AG
9.3.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.3.3 Novartis AG Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Teva Pharmaceutical Industries Ltd.
9.4.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.4.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AstraZeneca
9.5.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.5.3 AstraZeneca Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.6.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 GlaxoSmithKline plc
9.7.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.7.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Boehringer Ingelheim GmbH
9.8.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Neurological Disorder Drugs Product Profiles, Application and Specification
9.8.3 Boehringer Ingelheim GmbH Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Neurological Disorder Drugs Product Picture
Table Global Neurological Disorder Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Neurological Disorder Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Neurological Disorder Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Neurological Disorder Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Neurological Disorder Drugs Industry Development
Table Global Neurological Disorder Drugs Sales Volume by Player (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume Share by Player (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Share by Player in 2021
Table Neurological Disorder Drugs Revenue (Million USD) by Player (2017-2022)
Table Neurological Disorder Drugs Revenue Market Share by Player (2017-2022)
Table Neurological Disorder Drugs Price by Player (2017-2022)
Table Neurological Disorder Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurological Disorder Drugs Sales Volume, Region Wise (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Neurological Disorder Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Neurological Disorder Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share, Region Wise in 2021
Table Global Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume by Type (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Market Share by Type in 2021
Table Global Neurological Disorder Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share by Type in 2021
Table Neurological Disorder Drugs Price by Type (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Antipsychotic (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Antipsychotic (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Hypnotic & Sedative (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Hypnotic & Sedative (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Analgesics (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Analgesics (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Anticoagulants (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Anticoagulants (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Neurological Disorder Drugs Consumption by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption Market Share by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2017-2022)
Table Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2017-2022)
Table Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Neurological Disorder Drugs Price and Trend Forecast (2022-2027)
Figure USA Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Neurological Disorder Drugs Market Sales Volume Forecast, by Type
Table Global Neurological Disorder Drugs Sales Volume Market Share Forecast, by Type
Table Global Neurological Disorder Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Neurological Disorder Drugs Revenue Market Share Forecast, by Type
Table Global Neurological Disorder Drugs Price Forecast, by Type
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Antipsychotic (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Antipsychotic (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Hypnotic & Sedative (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Hypnotic & Sedative (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Analgesics (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Analgesics (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Anticoagulants (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Anticoagulants (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Neurological Disorder Drugs Market Consumption Forecast, by Application
Table Global Neurological Disorder Drugs Consumption Market Share Forecast, by Application
Table Global Neurological Disorder Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Neurological Disorder Drugs Revenue Market Share Forecast, by Application
Figure Global Neurological Disorder Drugs Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Neurological Disorder Drugs Consumption Value (Million USD) and Growth Rate of Clinic (2022-2027)
Figure Global Neurological Disorder Drugs Consumption Value (Million USD) and Growth Rate of Home (2022-2027)
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Merck & Co. Profile
Table Merck & Co. Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Neurological Disorder Drugs Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Boehringer Ingelheim GmbH Revenue (Million USD) Market Share 2017-2022
Figure Neurological Disorder Drugs Product Picture
Table Global Neurological Disorder Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Neurological Disorder Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Neurological Disorder Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Neurological Disorder Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Neurological Disorder Drugs Industry Development
Table Global Neurological Disorder Drugs Sales Volume by Player (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume Share by Player (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Share by Player in 2021
Table Neurological Disorder Drugs Revenue (Million USD) by Player (2017-2022)
Table Neurological Disorder Drugs Revenue Market Share by Player (2017-2022)
Table Neurological Disorder Drugs Price by Player (2017-2022)
Table Neurological Disorder Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurological Disorder Drugs Sales Volume, Region Wise (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Neurological Disorder Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Neurological Disorder Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share, Region Wise in 2021
Table Global Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume by Type (2017-2022)
Table Global Neurological Disorder Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume Market Share by Type in 2021
Table Global Neurological Disorder Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share by Type in 2021
Table Neurological Disorder Drugs Price by Type (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Antipsychotic (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Antipsychotic (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Hypnotic & Sedative (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Hypnotic & Sedative (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Analgesics (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Analgesics (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Anticoagulants (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Anticoagulants (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Neurological Disorder Drugs Consumption by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption Market Share by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2017-2022)
Table Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2017-2022)
Table Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2017-2022)
Figure Global Neurological Disorder Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Neurological Disorder Drugs Price and Trend Forecast (2022-2027)
Figure USA Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Disorder Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Disorder Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Neurological Disorder Drugs Market Sales Volume Forecast, by Type
Table Global Neurological Disorder Drugs Sales Volume Market Share Forecast, by Type
Table Global Neurological Disorder Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Neurological Disorder Drugs Revenue Market Share Forecast, by Type
Table Global Neurological Disorder Drugs Price Forecast, by Type
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Antipsychotic (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Antipsychotic (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Hypnotic & Sedative (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Hypnotic & Sedative (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Analgesics (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Analgesics (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Anticoagulants (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Anticoagulants (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Neurological Disorder Drugs Market Consumption Forecast, by Application
Table Global Neurological Disorder Drugs Consumption Market Share Forecast, by Application
Table Global Neurological Disorder Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Neurological Disorder Drugs Revenue Market Share Forecast, by Application
Figure Global Neurological Disorder Drugs Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Neurological Disorder Drugs Consumption Value (Million USD) and Growth Rate of Clinic (2022-2027)
Figure Global Neurological Disorder Drugs Consumption Value (Million USD) and Growth Rate of Home (2022-2027)
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Merck & Co. Profile
Table Merck & Co. Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Neurological Disorder Drugs Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Volume and Growth Rate
Figure Boehringer Ingelheim GmbH Revenue (Million USD) Market Share 2017-2022
